MIRM

73.28

1.40% 1.11

Handel nachbörslich: 73.28

Mirum Pharmaceuticals Inc (MIRM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MIRM? Forum Prognose

Schlusskurs vom Vortag:

$72.17

Offen:

$71.88

24-Stunden-Volumen:

375.88K

Relative Volume:

0.53

Marktkapitalisierung:

$3.68B

Einnahmen:

$379.25M

Nettoeinkommen (Verlust:

$-77.34M

KGV:

-45.45

EPS:

-1.6122

Netto-Cashflow:

$-27.87M

1W Leistung:

-0.76%

1M Leistung:

-1.52%

6M Leistung:

+84.84%

1J Leistung:

+84.01%

1-Tages-Spanne:

$71.78

$73.66

1-Wochen-Bereich:

$71.43

$78.54

52-Wochen-Spanne:

$36.88

$78.54

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Firmenname

Mirum Pharmaceuticals Inc

Sektor

Healthcare (1146)

Branche

Biotechnology (639)

Telefon

650-667-4085

Adresse

989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY

Mitarbeiter

349

Twitter

@mirumpharma

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

MIRM's Discussions on Twitter

Vergleichen Sie MIRM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MIRM Mirum Pharmaceuticals Inc	73.28	3.63B	379.25M	-77.34M	-27.87M	-1.6122
VRTX Vertex Pharmaceuticals Inc	412.22	104.45B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	469.36	60.95B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	572.60	59.11B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	812.95	49.23B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.94	35.92B	4.56B	-176.77M	225.30M	-1.7177

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-24	Eingeleitet	TD Cowen	Buy
2025-08-11	Fortgesetzt	Stifel	Buy
2025-05-19	Fortgesetzt	H.C. Wainwright	Buy
2024-04-17	Eingeleitet	Stifel	Buy
2023-12-18	Bestätigt	H.C. Wainwright	Buy
2023-11-20	Fortgesetzt	JP Morgan	Overweight
2023-11-13	Eingeleitet	Morgan Stanley	Overweight
2023-10-24	Eingeleitet	Cantor Fitzgerald	Overweight
2023-10-17	Fortgesetzt	Evercore ISI	Outperform
2023-09-20	Eingeleitet	JMP Securities	Mkt Outperform
2022-09-01	Eingeleitet	Citigroup	Buy
2021-09-20	Eingeleitet	JP Morgan	Overweight
2020-08-07	Hochstufung	Raymond James	Outperform → Strong Buy
2020-08-03	Eingeleitet	H.C. Wainwright	Buy
2020-07-31	Eingeleitet	Piper Sandler	Overweight
2020-06-25	Eingeleitet	Robert W. Baird	Outperform
2019-08-12	Eingeleitet	Citigroup	Buy
2019-08-12	Eingeleitet	Evercore ISI	Outperform
2019-08-12	Eingeleitet	Guggenheim	Buy
2019-08-12	Eingeleitet	ROTH Capital	Buy
2019-08-12	Eingeleitet	Raymond James	Outperform

Alle ansehen

Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten

10:56 AM

Will Livmarli Continue to Drive Mirum's Top Line in Q3 Earnings? - Yahoo

10:56 AM

05:21 AM

Why Mirum Pharmaceuticals Inc. stock remains undervaluedMarket Rally & Risk Managed Investment Strategies - newser.com

05:21 AM

03:24 AM

Technical signs of recovery in Mirum Pharmaceuticals Inc.Bull Run & Real-Time Chart Breakout Alerts - newser.com

03:24 AM

02:09 AM

How to integrate Mirum Pharmaceuticals Inc. into portfolio analysis toolsTrade Volume Report & Risk Controlled Daily Plans - newser.com

02:09 AM

Oct 13, 2025

How to build a custom watchlist for Mirum Pharmaceuticals Inc.Trade Volume Summary & Safe Capital Investment Plans - newser.com

Oct 13, 2025

Is it time to cut losses on Mirum Pharmaceuticals Inc.Portfolio Risk Summary & AI Powered Market Trend Analysis - newser.com

Oct 13, 2025

How to use a screener to detect Mirum Pharmaceuticals Inc. breakoutsProduct Launch & Real-Time Chart Pattern Alerts - newser.com

Oct 13, 2025

Oct 12, 2025

Volume spikes in Mirum Pharmaceuticals Inc. stock – what they mean2025 Trade Ideas & Verified Short-Term Plans - newser.com

Oct 12, 2025

Oct 10, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Up 6.9%Should You Buy? - MarketBeat

Oct 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The AI Journal

Oct 10, 2025

Is Mirum Pharmaceuticals Inc. reversing from oversold territory2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com

Oct 10, 2025

Mirum Pharmaceuticals' (MIRM) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025

Can Mirum Pharmaceuticals Inc. (08D) stock survive global slowdownInflation Watch & Low Drawdown Investment Ideas - newser.com

Oct 10, 2025

Is Mirum Pharmaceuticals Inc 08D a good long term investmentRisk Management Strategies & Affordable Portfolio Trading - earlytimes.in

Oct 10, 2025

Will Mirum Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Daily Profit Focused Screening - newser.com

Oct 10, 2025

Oct 09, 2025

Branded Website for Consumers 2025 - Medical Marketing and Media

Oct 09, 2025

Mirum Pharmaceuticals stock hits all-time high at 78.23 USD - Investing.com

Oct 09, 2025

Mirum Pharmaceuticals stock hits all-time high at 78.23 USD By Investing.com - Investing.com Australia

Oct 09, 2025

What data driven models say about Mirum Pharmaceuticals Inc.’s futureJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com

Oct 09, 2025

Will Mirum Pharmaceuticals Inc. stock recover faster than peersIndex Update & Risk Controlled Daily Trade Plans - newser.com

Oct 09, 2025

Oct 06, 2025

Custom watchlist performance reports with Mirum Pharmaceuticals Inc.2025 Trading Recap & Stock Portfolio Risk Control - newser.com

Oct 06, 2025

Is Mirum Pharmaceuticals Inc. stock near bottom after declineDollar Strength & Free Real-Time Market Sentiment Alerts - newser.com

Oct 06, 2025

Why Mirum Pharmaceuticals Inc. (08D) stock is listed among top recommendationsQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

How sentiment analysis helps forecast Mirum Pharmaceuticals Inc.Sell Signal & AI Enhanced Trading Signals - newser.com

Oct 05, 2025

Identifying reversal signals in Mirum Pharmaceuticals Inc.July 2025 Technicals & Daily Entry Point Alerts - newser.com

Oct 05, 2025